Relationship between cytomegalovirus (<scp>CMV</scp>) reactivation, <scp>CMV</scp>‐driven immunity, overall immune recovery and graft‐versus‐leukaemia effect in children
Mohamed Jeljeli(Inserm), Ghislaine Sterkers(Délégation Paris 7), Jean‐Hugues Dalle(Inserm), O Marie(Hôpital Necker-Enfants Malades), Karima Yakouben(Délégation Paris 7), Sandrine Leveillé(Délégation Paris 7), Débora Jorge Cordeiro(Délégation Paris 7), Valérie Guérin‐El Khourouj(Délégation Paris 7), Raphaël Porcher(Hotel Dieu Hospital), Jérôme LeGoff(Inserm), Béatrice Pédron(Hôpital Robert-Debré), Mony Fahd(Délégation Paris 7), André Baruchel(Université Paris Cité)
Cited by 37
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606